Management of patients with stroke and a patent foramen ovale

被引：0

作者：

Rodriguez C.J. ^{[1
]}

Homma S. ^{[1
]}

机构：

[1] Department of Medicine, Columbia Univ. Coll. Phys./Surgeons, New York, NY 10032

来源：

Current Neurology and Neuroscience Reports | 2004年 / 4卷 / 1期

关键词：

Surgical Closure; Transcatheter Closure; Cryptogenic Stroke; Paradoxical Embolism; Atrial Septal Aneurysm;

D O I：

10.1007/s11910-004-0006-8

中图分类号：

学科分类号：

摘要：

Observational studies have established a strong association between the presence of patent foramen ovale (PFO) and increased risk of ischemic stroke. The mechanism involved is presumed to be a paradoxical embolism from a venous thrombus that travels via the PFO to the systemic circulation. The best treatment modality to prevent recurrent stroke in patients with PFO remains undefined. There are four major choices: 1) medical therapy with anticoagulants, 2) medical therapy with antiplatelet agents, 3) surgical closure, and 4) percutaneous device closure. The Patent Foramen Ovate in Cryptogenic Stroke Study has demonstrated that antiplatelet and anticoagulant therapies are of equal benefit in preventing recurrent neurologic events in stroke patients with a PFO. Medical therapy should remain as the initial choice of secondary prophylactic therapy. PFO closure, either surgical or percutaneous, may further reduce event rates; however, this remains to be demonstrated because no randomized trial to date has compared PFO closure with medical therapy. Copyright © 2004 by Current Science Inc.

引用

页码：19 / 22

页数：3

共 33 条

[1] Franson S.V., The Botallo mystery, Clin. Cardiol., 22, pp. 434-436, (1999)
[2] Hagen P.T., Scholz D.G., Edwards W.D., Incidence and size of PFO during the first 10 decades of life: An autopsy study of 965 normal hearts, Mayo Clin. Proc., 59, pp. 17-20, (1984)
[3] Homma S., Di Tullio M.R., Sacco R.L., Patent foramen ovale and ischemic stroke, Stroke: Pathophysiology, Diagnosis, and Management, pp. 1013-1024, (1998)
[4] Meissner I., Whinant J.P., Khandheria B.K., Et al., Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: The SPARC Study, Mayo Clin. Proc., 74, pp. 862-869, (1999)
[5] Cohnheim J., Thrombose und embolie: Vorslesung über allgemeine, Pathologie, (1877)
[6] Webster M.W., Chancellor A.M., Smith H.J., Et al., Patent foramen ovale in young stroke patients, Lancet, 2, pp. 11-12, (1988)
[7] Lechat P., Mas J.L., Lescault G., Et al., Prevalence of patent foramen ovale in patients with stroke, N. Engl. J. Med., 318, pp. 1148-1152, (1988)
[8] Di Tullio M.R., Sacco R.L., Gopal A., Et al., Patent foramen ovale as a risk factor for cryptogenic stroke, Ann. Intern. Med., 117, pp. 461-465, (1992)
[9] Massaro A.R., Hoffman M., Sacco R.L., Et al., Detection of paradoxical cerebral embolism using transcranial Doppler in a patient with infarct of undetermined cause, Cerebrovasc. Dis., 3, pp. 116-119, (1993)
[10] Di Tullio M.R., Sacco R.L., Venketasubramanian N., Et al., Comparison of diagnostic techniques for the detection of a PFO in stroke patients, Stroke, 24, pp. 1020-1024, (1993)

← 1 2 3 4 →